Nov 08, 2023 from 11:00 AM to 12:00 PM EST
AACE's Live Webinars on Improving Obesity Diagnosis and Treatment through Endocrinology and Primary Care Collaboration offer an extension and further exploration from the enduring modules.
Live webinars focus on case-based learning (dilemma/decision case types) to allow learners to discuss methods, tactics, and examples to enhance skills:
- Destigmatize obesity to initiate and enhance patient engagement to initiate healthy weight conversation and facilitate discussions on evidence-based obesity treatments. (How to start the conversation, tips/tools)
- Manage obesity with shared decision-making, including AOM pharmacotherapy, bariatric surgery, behavior, and lifestyle interventions to achieve and maintain clinically meaningful, long-term weight loss.
- Implement strategies that lead to improved patient adherence in obesity care.
Check out the free, self-paced enduring modules with 3.75 hours of CME: https://pro.aace.com/education-and-event/product/improving-obesity-diagnosis
Upon successful completion of the program, participants should be better able to:
- Recognize obesity as a chronic, serious disease warranting diagnosis, long-term management, and early intervention to minimize associated comorbidities and psychosocial health consequences.
- Identify the biological basis of obesity including the role of genetics and hormones on appetite and energy regulation, metabolic adaptation to weight loss, and cardiometabolic risk factors.
- Destigmatize obesity to initiate and enhance patient engagement in healthy weight conversations and facilitate discussions on evidence-based obesity treatments in healthcare settings.
- Manage obesity with shared decision making, including AOM pharmacotherapy, bariatric surgery, behavior, and lifestyle interventions to achieve and maintain clinically meaningful, long-term weight loss.
- Implement strategies that lead to improved patient adherence in obesity care.
- Primary care physicians (PCPs)
- Physicians in-training
- Nurse practitioners (NPs)
- Physician assistants (PAs)
- Registered dietitians (RDs)
- Nurses
- Other health care providers (HCPs).
The American College of Endocrinology (ACE) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The American College of Endocrinology (ACE) designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credit(s). Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ABIM MOC
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1 MOC point in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Only those who receive a passing score will be eligible for MOC credit.
Please allow two weeks for MOC points to appear within your account on the ABIM website. Participation information will be shared.
Nursing
American Association of Clinical Endocrinology is approved by the California Board of Registered Nursing, Provider Number 17762, for 1 contact hour.
ABOM
Applicants for certification through the American Board of Obesity Medicine (ABOM) may claim up to 1 Group Two CME credit toward the ABOM application requirement.
The American Association of Clinical Endocrinologists (AACE) remains strongly committed to providing the best available evidence based clinical information to participants of this educational activity and requires an open disclosure of any potential conflict of interest identified by our faculty members. It is not the intent of AACE to eliminate all situations of potential conflict of interest, but rather to enable those who are working with AACE to recognize situations that may be subject to question by others. All disclosed conflicts of interest are reviewed by the CME Subcommittee to ensure that such situations are properly evaluated and, if necessary, resolved. AACE educational standards pertaining to conflict of interest are intended to maintain the professional autonomy of the clinical experts inherent in promoting a balanced presentation of science. Through our review process, all AACE accredited activities are ensured of independent, objective, scientifically balanced presentations of information. Disclosure of any or no relationships will be made available for all educational activities.
All of the relevant financial relationships listed for these individuals have been mitigated. All other planners for this educational activity have no relevant financial relationships to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All of the relevant financial relationships listed for these individuals have been mitigated.
Planners
- Monica Agarwal, MD, FACE, MEHP - Nothing to Disclose
- Jaime Almandoz, MD - NovoNordisk, Eli Lilly - Advisory Boards
- Sandhya Bassin, MD - Nothing to Disclose
- Elizzabeth Bauer, MD, FACP - Nothing to Disclose
- Karla Saint Andre, MD - Rythm, Novartis, Karyopharm, Pacific, Viatris, Novo, Rockley, Amgen - Stocks
- Diane Alberson, MEd, CAE - Nothing to Disclose
Faculty
- Brandi Addison, DO, FACE - Nothing to Disclose
- Jaime Almandoz, MD - NovoNordisk, Eli Lilly - Advisory Boards
- Sandhya Bassin, MD - Nothing to Disclose
- Elizabeth Bauer, MD, FACP - Nothing to Disclose
- Karla Saint Andre, MD - Rythm, Novartis, Karyopharm, Pacific, Viatris, Novo, Rockley, Amgen - Stocks
This activity is supported by independent educational grants from Eli Lilly and Rhythm Pharmaceuticals.